Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-12-18
1978-02-14
Helfin, Bernard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424317, 26034843, 260290R, 26034849, 424319, 260290V, 424341, 26034858, 260290HL, 26034863, 26029373, 560 189, 26029379, 560 45, 26029382, 542427, 26029383, 560 65, 2603409R, 560 64, 560 55, 260448R, 560 74, 2605005H, 260519, 260520R, 260520B, 260520E, 260543R, 260573, 260609R, 260613R, 260516, 260518R, 260518A, 424266, 424285, 424310, 424330, 424337, A61K 31235, C07C 6514, C07C 6976
Patent
active
040739350
ABSTRACT:
New 1,3-disubstituted propanol-(2) derivatives and their nicotinic acid esters of the general formula ##STR1## and their therapeutically acceptable salts, processes for preparing the same and the use thereof and pharmaceutical preparations containing the same for the treatment of hyperlipemia.
REFERENCES:
patent: 2738351 (1956-03-01), Dickinson et al.
Grill Helmut
Hofrichter Gernot
Janiak P. Stefan
Wagner Josef
Zschocke Rainer H.
Breitenstein G. T.
Helfin Bernard
Klinge Pharma GmbH & Co.
LandOfFree
Substituted propanol-(2)-derivatives and their nicotinic acid es does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted propanol-(2)-derivatives and their nicotinic acid es, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted propanol-(2)-derivatives and their nicotinic acid es will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-524941